Your search returned 2 results.

Results
	1.	Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C2 study): a randomized controlled trial. [electronic resource] by Tapson, Victor F Jing, Zhi-Cheng Xu, Kai-Feng Pan, Lei Feldman, Jeremy Kiely, David G Kotlyar, Eugene McSwain, C Shane Laliberte, Kevin Arneson, Carl Rubin, Lewis J Producer: 20140107 In: Chest vol. 144 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Dose proportionality of treprostinil sodium administered by continuous subcutaneous and intravenous infusion. [electronic resource] by McSwain, C Shane Benza, Ray Shapiro, Shelley Hill, Nicholas Schilz, Robert Elliott, C Gregory Zwicke, Dianne L Oudiz, Ronald J Staszewski, James P Arneson, Carl P Wade, Michael Zaccardelli, David McLaughlin, Vallerie Producer: 20080418 In: Journal of clinical pharmacology vol. 48 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search